Canaccord Genuity Maintains Hold on Beauty Health, Lowers Price Target to $1.25
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Susan Anderson maintains a Hold rating on Beauty Health (NASDAQ:SKIN) and lowers the price target from $2 to $1.25.
August 12, 2024 | 11:56 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Canaccord Genuity analyst Susan Anderson maintains a Hold rating on Beauty Health (NASDAQ:SKIN) and lowers the price target from $2 to $1.25.
The lowered price target from $2 to $1.25 by Canaccord Genuity suggests a negative outlook on Beauty Health's stock performance, likely leading to a short-term decline in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100